The failure of a propellant tank during testing will delay the first launch of Rocket Lab’s Neutron rocket to at least the ...

Neutron delays manageable, sales up 16% in Q4 2025, $1.85B backlog. Read here for a detailed investment analysis.

If the company can get its rocket of the future to an official launch, it stands to do very well indeed.

Rocket Lab's revenue has surged, with its Space Systems segment generating nearly $200 million last year. At 65 times sales, the stock is priced for near-perfect execution, leaving little room for ...

Shares of Rocket Lab (NASDAQ: RKLB) have pulled back sharply over the past week, closing Monday, Jan. 26, nearly 20% below its recent all-time high. The sell-off came despite continued momentum across ...

Rocket Lab (RKLB) is back in focus after a critical Neutron rocket test failure raised fresh questions about its 2026 development timeline, putting execution risk at the center of the stock story. See ...

Stay on This Page Pinned Feb 26, 2026 at 3:30 PM EST We are updating this story in real time as new information breaks. Stay on this page for the latest developments, key quotes, numbers, and market ...

Rocket Lab is right on the cusp of becoming a sustainable and attractive business. And over the next five years, it could become a viable alternative to industry leaders like SpaceX. Still, with a ...

Detailed price information for Rocket Lab Corporation (RKLB-Q) from The Globe and Mail including charting and trades.

Rocket Lab’s growing defense contracts, expanding Space Systems segment, and visible backlog conversion create durable revenue growth. Read why RKLB is a Buy.